Business wins health plan delay
The Obama administration plans to postpone a key requirement of the president's health law, delaying until 2015 penalties on large employers that don't offer health coverage. The one-year delay, announced...
Home > Reviews
All Stories
Walgreen seeks remedy to weak quarter
Despite its presence on seemingly every major street corner in every major city, Walgreen Co. needs to get more customers coming through its 8,560 doors. The Deerfield-based drugstore chain, the...
Walgreen misses 3Q expectations, shares slide
Shares of Walgreen Co. fell Tuesday after the Deerfield-based drug store retailer reported a softer-than-expected third quarter that missed analysts' estimates. Citing a weak economy and sluggish non-pharmacy sales, Walgreen...
Tenet to enter Chicago market with Vanguard deal
Dallas-based hospital operator Tenet Healthcare Corp. is making a push into the Chicago market with a deal to buy Vanguard Health Systems Inc. for about $1.73 billion plus the assumption...
Critics say Medicare competitive bidding program not ready to fly
Less than two weeks before Medicare plans to roll out a program that aims to cut prices for some of the most-used home medical devices and supplies, members of Congress...
Headlines say small hospitals are in trouble. But how much, and for how much longer? We wanted to look.
Readers may have seen the news that the state of Illinois bailed out failing Roseland Community Hospital on Chicago's Far South Side, a small safety-net hospital that's on the brink...
Headlines say small hospitals are in trouble. But how much, and for how much longer? We wanted to look.
Readers may have seen the news that the state of Illinois bailed out failing Roseland Community Hospital on Chicago's Far South Side, a small safety-net hospital that's on the brink...
Supreme Court rules for generics in AbbVie ‘pay for delay’ case
WASHINGTON -- Stemming from a case involving a male hormone from AbbVie Inc, the Supreme Court ruled Monday that brand-name drug makers can be sued if they pay a potential...
Supreme Court rules for generics in AbbVie ‘pay for delay’ case
WASHINGTON -- Stemming from a case involving a male hormone from AbbVie Inc, the Supreme Court ruled Monday that brand-name drug makers can be sued if they pay a potential...
Catamaran shares continue climb on Cigna deal
Catamaran Corp. shares continued their climb Tuesday, adding more than 10 percent, to $53.99, on news that it renewed its its announced a 10-year contract with health insurer Cigna Corp....